Mikhail Ivanovich Papisov, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iodine Radioisotopes | 4 | 2012 | 1028 | 0.690 |
Why?
|
| Acids, Heterocyclic | 1 | 2012 | 1 | 0.480 |
Why?
|
| Sulfuric Acid Esters | 1 | 2012 | 28 | 0.470 |
Why?
|
| Drug Delivery Systems | 4 | 2013 | 2210 | 0.420 |
Why?
|
| Polymers | 3 | 2005 | 1614 | 0.350 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 530 | 0.340 |
Why?
|
| Biocompatible Materials | 3 | 2005 | 1704 | 0.320 |
Why?
|
| Pentetic Acid | 4 | 2005 | 220 | 0.310 |
Why?
|
| Radiopharmaceuticals | 3 | 2019 | 2757 | 0.300 |
Why?
|
| Lymph Nodes | 5 | 2005 | 3424 | 0.270 |
Why?
|
| Contrast Media | 8 | 2019 | 5276 | 0.260 |
Why?
|
| Phagocytes | 1 | 2005 | 304 | 0.230 |
Why?
|
| Drug Carriers | 4 | 1996 | 686 | 0.230 |
Why?
|
| Positron-Emission Tomography | 5 | 2019 | 6270 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2015 | 8545 | 0.220 |
Why?
|
| Camptothecin | 1 | 2004 | 551 | 0.210 |
Why?
|
| Glycine | 1 | 2004 | 688 | 0.200 |
Why?
|
| Rats | 16 | 2019 | 24860 | 0.190 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2019 | 53 | 0.180 |
Why?
|
| Macromolecular Substances | 3 | 2013 | 1500 | 0.180 |
Why?
|
| Nanotechnology | 1 | 2005 | 697 | 0.180 |
Why?
|
| Tissue Distribution | 7 | 2019 | 2399 | 0.180 |
Why?
|
| Magnetics | 6 | 1988 | 643 | 0.160 |
Why?
|
| Isotope Labeling | 2 | 2019 | 423 | 0.160 |
Why?
|
| Dimethylformamide | 2 | 2015 | 22 | 0.160 |
Why?
|
| Drug Design | 2 | 2019 | 1099 | 0.150 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2015 | 10 | 0.140 |
Why?
|
| Axonal Transport | 2 | 2013 | 187 | 0.140 |
Why?
|
| Isradipine | 1 | 2015 | 14 | 0.140 |
Why?
|
| Organometallic Compounds | 2 | 1996 | 660 | 0.140 |
Why?
|
| Injections, Spinal | 2 | 2013 | 314 | 0.140 |
Why?
|
| Cations | 2 | 2005 | 240 | 0.130 |
Why?
|
| Rejuvenation | 1 | 2015 | 81 | 0.130 |
Why?
|
| Kinetics | 5 | 2005 | 6655 | 0.130 |
Why?
|
| Hydrolysis | 2 | 2005 | 684 | 0.130 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 330 | 0.120 |
Why?
|
| Carbohydrates | 2 | 2005 | 355 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 892 | 0.120 |
Why?
|
| Myosins | 1 | 1995 | 423 | 0.120 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 135 | 0.120 |
Why?
|
| Models, Chemical | 2 | 2005 | 633 | 0.120 |
Why?
|
| Triazoles | 1 | 2019 | 915 | 0.120 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 354 | 0.110 |
Why?
|
| Iduronate Sulfatase | 1 | 2012 | 9 | 0.110 |
Why?
|
| Glucose | 1 | 2005 | 4273 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 76 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2533 | 0.110 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2012 | 29 | 0.110 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 725 | 0.110 |
Why?
|
| Epidermis | 1 | 2015 | 539 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 700 | 0.110 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2012 | 81 | 0.110 |
Why?
|
| Solvents | 1 | 2012 | 295 | 0.110 |
Why?
|
| Ferric Compounds | 3 | 1993 | 413 | 0.110 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 1004 | 0.100 |
Why?
|
| Meninges | 1 | 2013 | 184 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 2599 | 0.100 |
Why?
|
| Haplorhini | 1 | 2011 | 581 | 0.100 |
Why?
|
| Rabbits | 6 | 2005 | 5061 | 0.100 |
Why?
|
| Animals | 25 | 2019 | 169420 | 0.100 |
Why?
|
| Proteins | 1 | 2005 | 6070 | 0.100 |
Why?
|
| Rats, Inbred F344 | 2 | 2005 | 878 | 0.090 |
Why?
|
| Dextrans | 4 | 2005 | 615 | 0.090 |
Why?
|
| Oxides | 3 | 1994 | 420 | 0.090 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 617 | 0.090 |
Why?
|
| Polysaccharides | 2 | 2005 | 995 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3898 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2005 | 3687 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 8 | 1996 | 34430 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1755 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2299 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 2007 | 392 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6324 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1995 | 2008 | 0.070 |
Why?
|
| Ketoses | 1 | 2005 | 3 | 0.070 |
Why?
|
| Models, Animal | 1 | 2013 | 2204 | 0.070 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 464 | 0.070 |
Why?
|
| Drug Stability | 2 | 2004 | 304 | 0.070 |
Why?
|
| Ethylenediamines | 1 | 2005 | 53 | 0.070 |
Why?
|
| Gels | 2 | 2005 | 434 | 0.070 |
Why?
|
| Polylysine | 1 | 2005 | 134 | 0.070 |
Why?
|
| Polyethylene Glycols | 2 | 2005 | 1177 | 0.070 |
Why?
|
| Tissue Engineering | 2 | 2005 | 1829 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2005 | 5467 | 0.070 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 156 | 0.070 |
Why?
|
| Biopolymers | 1 | 2005 | 191 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2012 | 1291 | 0.070 |
Why?
|
| Half-Life | 2 | 2015 | 674 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2005 | 13626 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 777 | 0.060 |
Why?
|
| Oxygen | 2 | 2005 | 4162 | 0.060 |
Why?
|
| Particle Size | 2 | 2005 | 1671 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2005 | 402 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 280 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 1996 | 1477 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 617 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2005 | 258 | 0.060 |
Why?
|
| Brain | 4 | 2019 | 25206 | 0.060 |
Why?
|
| Iron | 3 | 1994 | 1735 | 0.060 |
Why?
|
| Carbon | 1 | 2005 | 656 | 0.050 |
Why?
|
| Indium Radioisotopes | 3 | 1996 | 120 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1602 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 964 | 0.050 |
Why?
|
| Protons | 1 | 2005 | 1065 | 0.050 |
Why?
|
| Autoradiography | 2 | 2019 | 790 | 0.050 |
Why?
|
| Liposomes | 2 | 1994 | 744 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2004 | 1950 | 0.050 |
Why?
|
| Spiro Compounds | 1 | 2019 | 85 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 2 | 1985 | 1042 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2145 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10620 | 0.040 |
Why?
|
| Time Factors | 3 | 2005 | 40875 | 0.040 |
Why?
|
| Enzymes, Immobilized | 3 | 1988 | 44 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10284 | 0.040 |
Why?
|
| Mice | 5 | 2012 | 80375 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3801 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 3633 | 0.040 |
Why?
|
| Radioimmunodetection | 1 | 1995 | 47 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 1996 | 830 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 4905 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2015 | 208 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4688 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1996 | 1421 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 6035 | 0.030 |
Why?
|
| Siloxanes | 1 | 1993 | 26 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 11401 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2015 | 612 | 0.030 |
Why?
|
| Asialoglycoproteins | 1 | 1993 | 19 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1171 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2413 | 0.030 |
Why?
|
| Lymphatic Metastasis | 3 | 1996 | 2968 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 786 | 0.030 |
Why?
|
| Ferrosoferric Oxide | 3 | 1994 | 379 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1996 | 535 | 0.030 |
Why?
|
| Binding Sites | 2 | 2019 | 6214 | 0.030 |
Why?
|
| Silicones | 1 | 1993 | 247 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 1993 | 221 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4931 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1402 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2015 | 652 | 0.030 |
Why?
|
| Iron Chelating Agents | 1 | 1992 | 146 | 0.030 |
Why?
|
| Necrosis | 1 | 1995 | 1645 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 6881 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 951 | 0.020 |
Why?
|
| Dogs | 2 | 2012 | 4046 | 0.020 |
Why?
|
| Troponin C | 1 | 2007 | 27 | 0.020 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1988 | 54 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2012 | 512 | 0.020 |
Why?
|
| Streptokinase | 1 | 1988 | 189 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1996 | 3956 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 148 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16736 | 0.020 |
Why?
|
| Male | 10 | 2015 | 350324 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 745 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 2599 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 894 | 0.020 |
Why?
|
| Fibrinolytic Agents | 2 | 1988 | 2124 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6641 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17409 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1346 | 0.020 |
Why?
|
| Humans | 7 | 2013 | 715777 | 0.020 |
Why?
|
| Colloids | 1 | 1984 | 144 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2012 | 1808 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 3800 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 23729 | 0.010 |
Why?
|
| Microspheres | 1 | 1984 | 794 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6803 | 0.010 |
Why?
|
| Myocardium | 1 | 1995 | 4909 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3818 | 0.010 |
Why?
|
| Liver | 2 | 1993 | 7594 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4893 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1994 | 2032 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1756 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5102 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 9004 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11689 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9548 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 18199 | 0.010 |
Why?
|
| Female | 3 | 2015 | 377204 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 15059 | 0.010 |
Why?
|
| Chymotrypsin | 2 | 1986 | 152 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 49 | 0.010 |
Why?
|
| Femoral Nerve | 1 | 1994 | 41 | 0.010 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 1993 | 32 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1994 | 550 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1995 | 683 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 9375 | 0.010 |
Why?
|
| Surface Properties | 1 | 1994 | 1177 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1994 | 617 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1994 | 1167 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12305 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1974 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1993 | 1477 | 0.000 |
Why?
|
| Cyanogen Bromide | 1 | 1985 | 84 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1986 | 259 | 0.000 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1986 | 334 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 1160 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1985 | 600 | 0.000 |
Why?
|
| Fibrin | 1 | 1986 | 515 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1986 | 919 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1985 | 678 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1994 | 6105 | 0.000 |
Why?
|
| Thrombosis | 1 | 1986 | 2843 | 0.000 |
Why?
|